From FDA to MHRA: are drug regulators for hire?

BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1538 (Published 29 June 2022)Cite this as: BMJ 2022;377:o1538 Article Related contentMetrics Responses Maryanne Demasi, investigative journalist Author affiliations maryannedemasi@hotmail.com Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit the market. But do they have sufficient independence from the companies they are meant to regulate? Maryanne Demasi investigates Over the past